Evidence map›Paper›PMID 38543920›Full record

ArticleVaccines2024

Improving Vaccine Assessment Pathways and Decision Making in the Polish Immunization Program.

Marcin Czech, Ewa Augustynowicz, Michał Byliniak, Teresa Jackowska, Mikołaj Konstanty, Ernest Kuchar, Agnieszka Mastalerz-Migas, Maciej Niewada, Aneta Nitsch-Osuch, Iwona Paradowska-Stankiewicz and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Public spending on immunisation in Poland.Frontiers in public health · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Marcin CzechDepartment of Pharmacoeconomics, Institute of Mother and Child, 01-211 Warsaw, Poland.ORCID 0000-0001-7292-1712
Ewa AugustynowiczDepartment of Epidemiology of Infectious Diseases and Surveillance, National Institute of Public Health-National Institute of Hygiene-National Research Institute, 00-791 Warsaw, Poland.
Michał ByliniakINFARMA, The Employers' Union of Innovative Pharmaceutical Companies, 02-670 Warsaw, Poland.
Teresa JackowskaDepartment of Pediatrics, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.
Mikołaj KonstantySilesian Pharmaceutical Chamber, 40-637 Katowice, Poland.ORCID 0000-0001-7099-423X
Ernest KucharDepartment of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0002-7883-2427
Agnieszka Mastalerz-MigasPolish Society of Family Medicine, 51-141 Wrocław, Poland.
Maciej NiewadaDepartment of Experimental and Clinical Pharmacology, Medical University of Warsaw, 02-091 Warsaw, Poland.
Aneta Nitsch-OsuchDepartment of Social Medicine and Public Health, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0002-2622-7348
Iwona Paradowska-StankiewiczDepartment of Epidemiology of Infectious Diseases and Surveillance, National Institute of Public Health-National Institute of Hygiene-National Research Institute, 00-791 Warsaw, Poland.ORCID 0000-0001-7222-1337
Jarosław PinkasSchool of Public Health, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.ORCID 0000-0002-1015-9643
Jakub SzulcAlab Laboratories, 00-739 Warsaw, Poland.
Jacek WysockiDepartment of Preventive Medicine, Poznań University of Medical Sciences, 60-781 Poznań, Poland.

Funding

INFARMA NA
6 · The paper itself

Abstract

This study examines the vaccine market access pathway in Poland to evaluate its efficiency and propose recommendations for its improvement. The research spans a comprehensive analysis of the vaccine assessment process, ranging from pre-registration to sustainability, encompassing critical components such as national immunization technical advisory groups (NITAGs), health technology assessments, resource evaluations, and decision making. This investigation utilizes a multi-phase approach. Initial desk research aimed to collect accumulated evidence about each step of the vaccine access pathway. This constituted the background for an expert panel discussion (

Indexed as

decision makinghealth technology assessmentimmunization policiesmedicines policynational immunization technical advisory groupsPolandvaccine assessment

Identifiers

PMID38543920
PMCPMC10975328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.